Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.

Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E.

Emerg Infect Dis. 2013 Jan;19(1):61-8. doi: 10.3201/eid1901.120741.

2.

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

Andrews NJ, Waight PA, George RC, Slack MP, Miller E.

Vaccine. 2012 Nov 6;30(48):6802-8. doi: 10.1016/j.vaccine.2012.09.019. Epub 2012 Sep 18.

PMID:
23000122
3.

Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.

Harboe ZB, Valentiner-Branth P, Ingels H, Rasmussen JN, Andersen PH, Bjerre CC, Goldblatt D, Ashton L, Haston M, Konradsen HB, Lambertsen L; Danish Pneumococcal Surveillance Collaborating Group..

PLoS One. 2013;8(1):e51460. doi: 10.1371/journal.pone.0051460. Epub 2013 Jan 24.

4.

Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.

Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E.

Clin Infect Dis. 2014 Feb;58(4):517-25. doi: 10.1093/cid/cit791. Epub 2013 Dec 2.

PMID:
24300040
5.

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.

Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E.

Lancet Infect Dis. 2015 May;15(5):535-43. doi: 10.1016/S1473-3099(15)70044-7. Epub 2015 Mar 20. Erratum in: Lancet Infect Dis. 2015 Jun;15(6):629.

6.

Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.

Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R.

J Clin Microbiol. 2013 Mar;51(3):820-7. doi: 10.1128/JCM.01917-12. Epub 2012 Dec 26.

7.

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Albrich WC, Baughman W, Schmotzer B, Farley MM.

Clin Infect Dis. 2007 Jun 15;44(12):1569-76. Epub 2007 May 8.

PMID:
17516400
8.

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.

van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R, Miller E.

J Infect. 2012 Jul;65(1):17-24. doi: 10.1016/j.jinf.2012.02.017. Epub 2012 Mar 3.

PMID:
22394683
9.

Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.

van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R.

Vaccine. 2012 Aug 31;30(40):5880-5. doi: 10.1016/j.vaccine.2012.06.068. Epub 2012 Jul 4.

PMID:
22771186
10.

Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

American Academy of Pediatrics Committee on Infectious Diseases..

Pediatrics. 2010 Jul;126(1):186-90. doi: 10.1542/peds.2010-1280. Epub 2010 May 24.

PMID:
20498180
11.

Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and wales.

Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E.

Clin Infect Dis. 2013 Mar;56(5):633-40. doi: 10.1093/cid/cis934. Epub 2012 Nov 21.

PMID:
23175560
12.

The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.

Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D, Sprenger R, Bonnet E.

Adv Ther. 2013 Feb;30(2):127-51. doi: 10.1007/s12325-013-0007-6. Epub 2013 Feb 7. Review.

PMID:
23397399
13.

Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.

Yildirim I, Stevenson A, Hsu KK, Pelton SI.

Pediatr Infect Dis J. 2012 Oct;31(10):1016-21. doi: 10.1097/INF.0b013e3182615615.

PMID:
22673142
14.

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC.

Vaccine. 2011 Nov 15;29(49):9127-31. doi: 10.1016/j.vaccine.2011.09.112. Epub 2011 Oct 5.

PMID:
21983361
15.

Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease.

Ben-Shimol S, Greenberg D, Hazan G, Givon-Lavi N, Gottesman G, Grisaru-Soen G, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group..

Pediatr Infect Dis J. 2015 Apr;34(4):409-16. doi: 10.1097/INF.0000000000000604.

PMID:
25764098
16.

7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?

Choi YH, Jit M, Gay N, Andrews N, Waight PA, Melegaro A, George R, Miller E.

PLoS One. 2011;6(10):e26190. doi: 10.1371/journal.pone.0026190. Epub 2011 Oct 14.

17.

Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?

Weil-Olivier C, Gaillat J.

Vaccine. 2014 Apr 11;32(18):2022-6. doi: 10.1016/j.vaccine.2014.02.008. Epub 2014 Feb 22. Review.

PMID:
24565755
18.

Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.

Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group..

Vaccine. 2012 Oct 12;30(46):6600-7. doi: 10.1016/j.vaccine.2012.08.012. Epub 2012 Aug 30.

PMID:
22939907
20.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249

Supplemental Content

Support Center